 Connection
Jesse Hinckley to Humans
This is a "connection" page, showing publications Jesse Hinckley has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.253 |
|
|
|
-
Hinckley JD, Ferland JN, Hurd YL. The Developmental Trajectory to Cannabis Use Disorder. Am J Psychiatry. 2024 May 01; 181(5):353-358.
Score: 0.022
-
Hammond CJ, Hinckley JD. Responding to the Youth Fentanyl Crisis: Practical Guidance for Child Psychiatrists. J Am Acad Child Adolesc Psychiatry. 2024 Nov; 63(11):1063-1068.
Score: 0.022
-
Molinero K, Hinckley JD. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Psychiatr Clin North Am. 2023 12; 46(4):691-702.
Score: 0.021
-
Adams ZW, Marriott BR, Hulvershorn LA, Hinckley JD. Treatment of Adolescent Cannabis Use Disorders. Psychiatr Clin North Am. 2023 12; 46(4):775-788.
Score: 0.021
-
Adams ZW, Marriott BR, Hulvershorn LA, Hinckley J. Treatment of Adolescent Cannabis Use Disorders. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):141-155.
Score: 0.020
-
Molinero K, Hinckley JD. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):57-68.
Score: 0.020
-
Hinckley J, Bhatia D, Ellingson J, Molinero K, Hopfer C. The impact of recreational cannabis legalization on youth: the Colorado experience. Eur Child Adolesc Psychiatry. 2024 Mar; 33(3):637-650.
Score: 0.019
-
Winters DE, Brandon-Friedman R, Yepes G, Hinckley JD. Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use. Drug Alcohol Depend. 2021 02 01; 219:108479.
Score: 0.018
-
Hinckley JD, Saba L, Raymond K, Bartels K, Klawitter J, Christians U, Hopfer C. An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses. Cannabis Cannabinoid Res. 2022 02; 7(1):65-77.
Score: 0.017
-
Hinckley JD, Riggs P. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. Child Adolesc Psychiatr Clin N Am. 2019 07; 28(3):461-472.
Score: 0.016
-
Hinckley J, Di Paola J. Genetic basis of congenital platelet disorders. Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):337-42.
Score: 0.011
-
McCabe CJ, Ellingson JM, Hinckley JD, Stallings M, Hopfer C, Rhee SH, Corley RP, Gustavson DE, Ross JM, Wall TL. Directional associations between antisocial behavior and alcohol use disorder symptoms from adolescence through adulthood: A sibling comparison cross-lagged approach. Alcohol Clin Exp Res (Hoboken). 2025 Sep; 49(9):2092-2102.
Score: 0.006
-
Moore A, Lewis B, Farrior H, Hinckley J, Nixon SJ, Bhatia D. Impact of Pre-Adolescent Substance Familiarity on Subsequent Use: Longitudinal Analysis of Risk by Latent Classes in the Adolescent Brain Cognitive Development Sample. Subst Use Misuse. 2025; 60(1):1-11.
Score: 0.006
-
Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Psychiatr Clin North Am. 2023 12; 46(4):xiii-xv.
Score: 0.005
-
Olsavsky AK, Hinckley JD, Vidal C. Editorial: Marijuana Legalization and Suicide in Adolescents and Transitional-Age Youth: Important Future Directions for This Line of Research. J Am Acad Child Adolesc Psychiatry. 2024 Mar; 63(3):307-309.
Score: 0.005
-
Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):xiii-xv.
Score: 0.005
-
Bhatia D, Hinckley J, Mikulich S, Sakai J. Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes. J Addict Med. 2022 Jan-Feb 01; 16(1):e16-e22.
Score: 0.005
-
Gupta S, Heiman M, Duncan N, Hinckley J, Di Paola J, Shapiro AD. Variable bleeding phenotype in an Amish pedigree with von Willebrand disease. Am J Hematol. 2016 Oct; 91(10):E431-5.
Score: 0.003
-
Chen J, Hinckley JD, Haberichter S, Jacobi P, Montgomery R, Flood VH, Wong R, Interlandi G, Chung DW, López JA, Di Paola J. Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease. Blood. 2015 Jul 09; 126(2):262-9.
Score: 0.003
-
Noetzli L, Sanz PG, Brodsky GL, Hinckley JD, Giugni JC, Giannaula RJ, Gonzalez-Alegre P, Di Paola J. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2. Gene. 2014 Jan 01; 533(1):447-50.
Score: 0.003
-
Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW, Pluthero FG, Urban D, Fabbro S, Nixon B, Gadzinski R, Storck M, Wang K, Ryu GY, Jobe SM, Schutte BC, Moseley J, Loughran NB, Parkinson J, Weyrich AS, Di Paola J. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet. 2011 Jul 17; 43(8):738-40.
Score: 0.002
-
Fabbro S, Kahr WH, Hinckley J, Wang K, Moseley J, Ryu GY, Nixon B, White JG, Bair T, Schutte B, Di Paola J. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly. Blood. 2011 Mar 24; 117(12):3430-4.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|